Abstract
Radionuclides therapy (RNT) development is a multidisciplinary endeavor.
It requires expertise in radiochemistry, radiobiology, oncology, pharmacology, medical
physics, and nuclear medicine. Many pharmaceutical companies are not familiar with
the aspects of radiation and radionuclide therapy, and the deployment of RNT agents
for cancer therapy is also unfamiliar to the oncology community. When compared with
almost all other systemic cancer treatment options, RNT has shown efficacy with
minimal toxicity. Moreover, molecular radiobiology needs to be further explored to
gain knowledge of the bystander's radiation effect. It can lead to updating for systemic
radionuclide therapy concept. This paper aims to review radiation biology and
radionuclides concepts to better understand the importance of basic concepts of
ionizing radiation, particularly for a systemic cancer treatment option.
Keywords: Alpha particle, Auger electrons, Beta particle, Radionuclide induced bystander effects, Radionuclide targeted therapy, The abscopal effect.
Related Books
Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine
Cancer Metastasis and Cancer Stem Cell/Niche
Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature
Controversies in Neuro-Oncology
Current Advances in Breast Cancer Research: A Molecular Approach
Cutting Edge Therapies for Cancer in the 21st Century
Frontiers in Cancer Immunology
Frontiers in Cancer Immunology
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Frontiers in Clinical Drug Research - Anti-Cancer Agents